
Vials
MOTS-c 40mg
A mitochondrial-derived peptide studied as an exercise mimetic via AMPK activation and metabolic regulation.
MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP), encoded within the 12S rRNA region of the mitochondrial genome rather than nuclear DNA. It was first identified in a landmark 2015 Cell Metabolism paper (Lee et al.) as the first mitochondrial-encoded signal peptide shown to translocate to the cell nucleus and directly regulate nuclear gene expression — establishing an entirely new class of metabolic signalling molecule. In that and follow-up research, MOTS-c treatment prevented diet-induced obesity and reversed age-related muscle insulin resistance in mouse models. This 40mg lyophilised vial suits extended research protocols. Independent lab testing confirmed this batch at 99% purity with an actual content of 39.80mg, closely matching the 40mg label claim.
Specifications
Research Benefits
- Exercise-mimetic activity — The founding 2015 study showed MOTS-c prevented diet-induced obesity and reversed age-related muscle insulin resistance in mouse models.
- Insulin sensitivity — Studies demonstrate improved glucose uptake and metabolic regulation via AMPK activation.
- Fat metabolism — Investigated for promoting fatty acid oxidation and reducing fat accumulation.
- Mitochondrial function — Supports cellular energy production and mitochondrial biogenesis.
- Novel signalling mechanism — The first mitochondrial-encoded peptide shown to translocate to the nucleus and directly regulate gene expression.
How It Works
The 2015 discovery paper additionally showed MOTS-c can translocate to the cell nucleus under metabolic stress, where it directly regulates nuclear gene expression — the first mitochondrial-encoded peptide shown to do so, adding a second, still-being-characterised layer to its studied activity.
⚠ For Research Use Only
By purchasing, the buyer confirms this product is being acquired for legitimate research purposes and assumes full responsibility for its handling, storage, and use in compliance with all applicable local, national, and international laws.
More Vials

Vials
5-Amino-1MQ 50mg
A selective NNMT inhibitor studied for reducing fat-cell formation and preserving cellular NAD+ levels.
View
Vials
AOD-9604
A modified HGH fragment (176-191) studied for fat metabolism without growth-hormone-linked anabolic activity.
View
Vials
BPC-157 5mg
A gastric-derived pentadecapeptide extensively studied for tendon, gut and musculoskeletal tissue repair.
View